Among them, <i>EGFR</i> exon 18-25 kinase domain duplication (<i>EGFR</i>-KDD) mutations have been identified as a novel <i>EGFR</i> gene subtype in NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.